ICICI Securities
-
Cohance Q4 Profit Slumps 72%, ICICI Securities Downgrades to Reduce'
Cohance's Q4 and FY26 performance remained under pressure due to continued inventory de-stocking in two large pharma CDMO products, product-specific challenges in the API segment and a delay in the receipt of new orders at NJ Bio.
-
Tata Power Sees Fresh Target Price Hike After Q4 Results; ICICI Securities Stays Bullish — Check Potential Upside
Tata Power is eyeing foray in the evolving nuclear power opportunity in India, it has already started on activities such as land identification, and water allocation.
-
Tata Consumer Shares Upgraded To 'Buy' As ICICI Securities Hikes Price Target — Check New Potential Upside
Tata Consumer's FY26 performance increasingly suggests that the business is moving beyond a portfolio led largely by tea and salt into a more scaled and diversified food and beverage platform.
-
Westlife Foodworld Shares In Focus As ICICI Securities Maintains 'Reduce' After Q4 Results But Hikes Target Price — Here's Why
Although operating metrics are stabilising and South markets are seeing early recovery, Westlife FoodWorld's valuations appear ahead of the pace of underlying earnings recovery, adds the brokerage.
-
Godrej Consumer Q4 Results: ICICI Securities Maintains 'Add' Rating Amid Margin Headwinds — Check Target Price
The brokerage expects Godrej Consumer's home care to be the primary growth engine in India, outpacing the currently muted personal care, supported by stabilising international geographies and strong innovation, launch pipeline.
-
L&T Shares Get Downgraded by ICICI Securities After Q4 Results Amid Geopolitical Uncertainty — Check Trimmed Target Price
Given the uncertainty in execution triggered by the US-Iran war, ICICI Securities has downgraded L&T's shares to Add from Buy and had trimmed traget price- check details
-
BHEL Shares In Focus As ICICI Securities Hikes Target Price After Strong Q4 — Should You Buy?
Given the improving earnings trajectory, strong order pipeline, and better execution visibility, ICICI Securities believes BHEL is well-positioned for further rerating, supporting its positive stance on the stock.
-
Dr Lal Pathlabs Sees Target Price Cut From ICICI Securities After Q4 Results — Here's Why
The brokerage highlighted that network expansion, entry into high-end radiology and geographic diversification remain key growth drivers for Dr. Lal, though near-term risks include rising competition, regulatory challenges.
-
Bandhan Bank Gets Target Price Hike From ICICI Securities After Q4; Sees Up to 28% Upside — Here's Why
The brokerage sees Bandhan Bank as a key beneficiary of easing stress and growth revival in MFI.
-
Bajaj Housing Finance Shares May Rally 37% Says ICICI Securities After Q4 Results — Here's Why
Leveraging its diversified portfolio across home loan, LRD, DF, and LAP, Bajaj Housing Finance appears well positioned to capture broader market share, targeting a 5% share of home loan originations, up from the current 2.52.7%.
-
Adani Green Energy Target Price Raised by ICICI Securities After Q4 Results — Details Inside
Adani Green Energy has the strongest track record of developing renewables portfolio, says ICICI Securities.
-
L&T Tech: 5% Downside Seen As ICICI Securities Trims Target Price After Q4
The brokerage maintains itsneutral stance on L&T Tech, as execution remains paramount amid a slew of strategy and portfolio changes.
-
Sumitomo Chemicals Shares In Focus As ICICI Securities Initiates Coverage — Check Target Price
ICICI Securities believes that the company's unique positioning, solid credentials and reasonable valuation provide material upside.
-
Sun Pharma, Aurobindo, Gland Pharma Among ICICI Securities' Seven Top Picks Ahead of Q4 Results — Check Target Prices
Among the large-cap companies, the brokerage expects Lupin to post a decent showing, while India-focused companies like Torrent and Alkem will likely have a strong quarter.
-
TCS Q4 Results Review: ICICI Securities Maintains 'Add', But Trims Target Price — Here's Why
TCS saw improving market share in larger vendor consolidation and cost take-out deals, with five mega deal wins in FY26.
